Since the SLC7A11null variants do not grow in xenograft and cannot form colonies in clonogenic assays, (Figure 1G–1H) we used the xCT inhibitor erastin to test whether an xCT-targeted therapeutic could be used to sensitize tumor cells to ionizing radiation (IR). Here, SLC7A11 is linked to neoplasm.